It is now clear that B cell fate decisions are dependent upon BCR signaling, so that disruption of BCR signaling mechanisms in immature B cells can disrupt negative selection of self-reactive clones and lead to production of autoreactive B cells and autoimmune disease [5, 6]. This evidence concerns the gene BCR and autoimmune disease.